Macrolides

Details Macrolides Macrolides

2009-07-06

2010-06-22

Kifle, Bruck (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C540S456000

Reexamination Certificate

active

07741338

ABSTRACT:
The invention relates to the stabilization of poly-ene macrolides and to a particular macrolide obtained in crystalline form.

REFERENCES:
patent: 3929992 (1975-12-01), Surenda et al.
patent: 4079128 (1978-03-01), Lin et al.
patent: 4080445 (1978-03-01), Lin et al.
patent: 0 041 795 (1981-12-01), None
patent: 0 329 460 (1989-08-01), None
patent: 0 423 714 (1991-04-01), None
patent: 0 467 606 (1992-01-01), None
patent: 0 593 227 (1994-04-01), None
patent: 0 512 754 (2000-07-01), None
patent: 94/09010 (1994-04-01), None
patent: 96/41807 (1996-12-01), None
patent: 97/03654 (1997-02-01), None
patent: 98/04279 (1998-02-01), None
patent: 98/33482 (1998-08-01), None
Simulect basiliximab injection powder, for solution, Novartis Pharmaceutical Corporation, Revised Sep. 2005.
Neoral-cyclosporine capsule, liquid filed, Novartis Pharmaceutical Corporation, Revised Aug. 2005.
Rapamune (sirolimus) tablet, sugar coated for oral use, Wyeth Pharmaceuticals Inc., Revised Jul. 2008.

Affiliated with

Also associated with

Rating

Macrolides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Macrolides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrolides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4152983